Target intelligence / Profile preview

UV-induced cis-syn cyclobutane pyrimidine dimer (CPD) (CPD)

Target
CPD
Molecular classification
DNA lesion, DNA damage product, Photoproduct
01

Overview

UV-induced cis-syn cyclobutane pyrimidine dimers (CPDs) are the most prevalent form of DNA damage caused by exposure to ultraviolet radiation, specifically in the UVB (280–315 nm) and UVC ranges (Sinha & Häder, 2002). These lesions occur when two adjacent pyrimidine bases—typically two thymines or a cytosine and a thymine—undergo a photochemical reaction to form a four-membered cyclobutane ring (Cadet et al., 2005). The presence of CPDs causes significant structural distortion of the DNA helix, which can stall DNA polymerase and RNA polymerase, leading to cell cycle arrest or apoptosis (Sancar, 1996). If these dimers are not accurately repaired by the nucleotide excision repair (NER) pathway, they can result in UV-signature mutations (C to T transitions), which are primary drivers of skin cancers such as basal cell carcinoma and melanoma (Mouret et al., 2006). Therapeutic approaches include the use of topical liposomal delivery of DNA repair enzymes, such as T4 endonuclease V, to accelerate the removal of these lesions in high-risk individuals (Yarosh et al., 2001). Additionally, sunscreens act as a primary preventive measure by absorbing or reflecting the UV radiation that triggers CPD formation (Diffey, 2002).

Other names
Cyclobutane pyrimidine dimerThymine dimerPyrimidine dimerDNA photoproductcis-syn CPDUV-induced DNA lesion
02

Mechanism of action

Direct enzymatic repair of DNA lesions via nucleotide excision or base excision repair pathways; prevention of formation via UV filtration.

03

Biological functions

MutagenesisTranscription inhibitionReplication blockCell cycle arrestApoptosis inductionDNA damage response
04

Disease associations

Skin cancerMelanomaBasal cell carcinomaSquamous cell carcinomaXeroderma pigmentosumActinic keratosisPhotoaging
05

Safety considerations

CarcinogenesisImmunosuppressionPhotoagingMutagenic potential of unrepaired lesions
06

Interacting drugs

T4 endonuclease V

3 more in the full profile.

07

Biomarkers

CPD-specific monoclonal antibodiesUrinary CPD metabolitesCPD levels in skin biopsies

Beyond the preview

Go deeper on UV-induced cis-syn cyclobutane pyrimidine dimer (CPD) (CPD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UV-induced cis-syn cyclobutane pyrimidine dimer (CPD) (CPD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call